Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $329.6M in total; no superinvestor holds it.
Other share classesIVEVF
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +24 vs. previous quarter
- 88
- 13F valueReported value at the end of Q2 2026
- $329.6M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding IVA, Q2 2026
No superinvestor reported holding IVA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Inventiva S.A. insiders from Form 4, newest first.
No open-market purchases or sales by Inventiva S.A. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Inventiva S.A. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caligan Partners LP | 8,163,191 | $30.9M | 1.49% | +3,188,285+64.1% | Added |
| Samsara BioCapital, LLC | 6,314,805 | $23.9M | 1.96% | +1,120,000+21.6% | Added |
| Nantahala Capital Management, LLC | 5,372,786 | $20.3M | 0.62% | +5,372,786 | New |
| Paradigm Biocapital Advisors LP | 4,000,000 | $15.1M | 0.28% | 00.0% | Unchanged |
| Andera Partners | 3,633,181 | $13.7M | 6.65% | +1,815,000+99.8% | Added |
| ADAR1 Capital Management, LLC | 3,606,656 | $13.6M | 0.64% | +1,432,258+65.9% | Added |
| Millennium Management LLC | 3,512,174 | $13.3M | 0.01% | +524,561+17.6% | Added |
| Trails Edge Capital Partners, LP | 2,657,997 | $10.0M | 1.60% | 00.0% | Unchanged |
| Franklin Resources Inc | 2,642,611 | $9.99M | 0.00% | +181,046+7.4% | Added |
| Squadron Capital Management LLC | 2,435,000 | $9.20M | 3.15% | +1,900,000+355.1% | Added |